Tatiana Hurtado de Mendoza

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Christopher A Benedict · 1 shared grant, 2025 · strength 1.07
   • Grant Harnessing Cytomegalovirus (CMV)-specific T-cells for pancreatic cancer immunotherapy R21CA286198↗
2. Andrew M. Lowy · 4 shared papers, 2021–2026 · strength 0.76
   • Paper Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4223↗
   • Paper Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond. DOI 10.3390/cancers13194991↗
   • Paper Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker DOI 10.1101/2023.05.24.542137↗
3. Kazuki N. Sugahara · 2 shared papers, 2023–2026 · strength 0.43
   • Paper Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4223↗
   • Paper Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker DOI 10.1101/2023.05.24.542137↗
4. Yukihito Kuroda · 2 shared papers, 2023–2026 · strength 0.43
   • Paper Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4223↗
   • Paper Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker DOI 10.1101/2023.05.24.542137↗
5. Kodai Suzuki · 2 shared papers, 2023–2026 · strength 0.43
   • Paper Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4223↗
   • Paper Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker DOI 10.1101/2023.05.24.542137↗
6. Norio Miyamura · 2 shared papers, 2023–2026 · strength 0.43
   • Paper Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4223↗
   • Paper Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker DOI 10.1101/2023.05.24.542137↗
7. Jonathan Weitz · 2 shared papers, 2021–2023 · strength 0.33
   • Paper Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond. DOI 10.3390/cancers13194991↗
   • Paper Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreati… DOI 10.1158/0008-5472.can-22-3645↗
8. Hervé Tiriac · 1 shared paper, 2021 · strength 0.17
   • Paper Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond. DOI 10.3390/cancers13194991↗
9. Deepak Rohila · 1 shared paper, 2023 · strength 0.16
   • Paper Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreati… DOI 10.1158/0008-5472.can-22-3645↗
10. Shweta Joshi · 1 shared paper, 2023 · strength 0.16
    • Paper Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreati… DOI 10.1158/0008-5472.can-22-3645↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.